‘Nanomaterials: Evolution and Advancement Towards Therapeutic Drug Delivery’ gives the present status and future perspective of Polymeric nanoparticles, Liposomes, Carbon Nanotubes, Magnetic Nanoparticles, Silica Based nanomaterial, Hydrogels, Metallic Nanoparticles, Cyclodextrins, Poly (Lactide-Co-Glycolide) and its Copolymers.
Improvement of a vector for the delivery of therapeutic drug in a controlled and targeted fashion is still a major challenge in the treatment of many diseases. The conventional application of drugs may lead to many limitations including poor distribution, limited effectiveness, lack of selectivity and dose dependent oxicity etc.
Development of an efficient drug delivery system can surmount these problems Nanomaterials aided delivery of drug provides advantage by enhancing aqueous solubility that leads to improved bioavailability, increased resistant time in the body, decreased side effects by targeting the drug to the specific location, reduced dose dependent toxicity and protection of the drug from early release.
In this book, up-to-date studies illustrating the promising nanomaterials as drug carriers that are navigating the conventional barriers have been reported. A detailed account of various nanomaterials including polymeric nanoparticles, liposomes, dendrimers, micelles, carbon nanomaterials, magnetic nanoparticles, solid lipid-based nanoparticles, silica nanomaterials and hydrogels for drug delivery will be accounted.
###
About the Editor:
Dr. Surendra Nimesh is an internationally recognized nanotechnology expert for biological applications with specialization in drug and gene delivery. He is currently working as o UGC assistant professor in the Department of Biotechnology at the Central University of Rajasthan, India. He has authored several research and review articles in international peer-reviewed journals, book chapters, and 4 books. His area of interest includes nanotechnology for drug/gene/siRNA delivery for the treatment of cardiovascular diseases and breast cancer.
Dr. Nidhi Gupta received her MSc degree in Biomedical Science from Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, in 2004 and Ph.D. in Virology from the National Institute of Immunology (NII), India, in 2008. She worked as a postdoctoral fellow at the Clinical Research Institute of Montreal (2007-2008) and the McGill University (2011-2013), Montreal, Canada. She has successfully completed the DST Young Scientist project at the IIS University, India, sponsored by SERB, Indio. Currently, she is working as a senior research scientist at the IIS University, Jaipur. Her field of interest includes catalytic nucleic acids, siRNA, and nanotechnology for drug delivery.
Prof. Ramesh Chandra is a distinguished scientist, a fellow of the Royal Society of Chemistry, London, and an outstanding Biomedical Sciences researcher. He is the founder-director of Dr B. R. Ambedkar Center for Biomedical Research, University of Delhi. Professor Chandra has contributed largely in the field of chemical sciences and particularly in new drug discovery and development as well as drug metabolism. He has published more than 400 research papers in International journals of repute, including review articles/monographs, book chapters; Four of his chapters are also published in internationally acclaimed books.
Keywords:
Nanotechnology, Drug Delivery, Pharmacology, Medicinal Chemistry, Nanomedicine Nanotechnology, Solid Lipid Nanoparticles, Nanomedicine, Silica Nanoparticles, Drug Delivery, Nanoformulations, Nanoparticles, Nanosuspensions, Dynamic Light scattering, PLGA Nanoparticles, Liposomes, Fullerenes, Dedrimers , Vaccine delivery,Nanomicelles, Nanoemulsions, Carbon Nanotubes, Nanocarriers.
For further information, please visit: https:/
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.